NCT05461911

Brief Summary

A large number of studies are devoted to studying the effect of patient nutrition on the occurrence and treatment of pressure ulcers. Several studies, including the US National Long-term Treatment of Pressure Ulcers Study, have shown that weight loss and malnutrition were associated with a higher risk of pressure ulcers. One of the successful products specially created for the treatment of pressure ulcers and taking into account the results of research is the high-protein, energy-rich, ready-to-use enteral tube feeding food product Nutrison Advanced Cubison. It is a complete enteral nutritional supplement with an innovative nutrient composition for patients with chronic wounds, including pressure ulcers, or at increased risk of developing them. Taking into account the available data, it seems expedient to continue studying the unique combination of nutrients that make up the study food product Nutrison Advanced Cubison in order to develop the most effective nutritional protocols for patients at risk for the treatment and prevention of pressure ulcers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
Last Updated

July 18, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

July 12, 2022

Last Update Submit

July 14, 2022

Conditions

Keywords

StrokeTraumatic Brain Injury

Outcome Measures

Primary Outcomes (3)

  • Changes in the area of pressure ulcers in both groups during the study

    up to 4 weeks

  • The proportion of patients in both groups with a decrease in the area of the pressure ulcer by 20% or more by the date of completion of observations

    up to 4 weeks

  • Changes in the Pressure Ulcer Scale for Healing values in both groups during the study

    Pressure Ulcer Scale for Healing (PUSH) is a common tool to monitor pressure healing over time. The PUSH Tool monitors three parameters: surface area of the wound, wound exudate and type of wound tissue. Minimum value is 0, maximum value is 17. The bigger scale is the worse

    up to 4 weeks

Secondary Outcomes (5)

  • Duration of treatment for pressure ulcers in study patients

    up to 4 weeks

  • Frequency and duration of infectious complications of pressure ulcers in study patients

    up to 4 weeks

  • Concentration of the blood albumin at the beginning and at the end of observations

    up to 4 weeks

  • Concentration of the blood lymphocytes at the beginning and at the end of observations

    up to 4 weeks

  • Concentration of the C-reactive protein at the beginning and at the end of observations

    up to 4 weeks

Study Arms (2)

The Study Group

30 adult patients aged 30-75 years to receive a specialized tube feeding product Nutrison Advanced Cubison (20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support for patients with pressure ulcers during the entire observation period

Dietary Supplement: Nutrison Advanced Cubison

The Control Group

30 patients aged 30-75 years to receive a standard (available in the clinic) tube feeding product (energetically similar to the product in group 1) with a standard content of arginine, vitamins and minerals from calculating the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g protein / kg body weight / day according to the recommendations for nutritional support for patients with pressure ulcers during the entire observation period

Interventions

Nutrison Advanced CubisonDIETARY_SUPPLEMENT

(20% protein energy 100 kcal, 5.5 g protein, 0.85 g arginine, 38 mg of vitamin C and 2 mg of zinc) in a volume not exceeding 1.5 liters / day and, if necessary, to replenish nutritional needs based on the total daily intake of 30-35 kcal / kg / day and 1.2-1.5 g of protein / kg body weight / day according to the recommendations for nutritional support

The Study Group

Eligibility Criteria

Age30 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

60 patients hospitalized with strokes or traumatic brain injury, who are on tube feeding and with the presence of pressure ulcers of 2-3 stages identified at baseline or during hospital stay

You may qualify if:

  • Patients diagnosed with stroke / TBI and who are on tube feeding
  • Presence of pressure ulcers of 2-3 stages
  • Informed voluntary consent to medical intervention is formalized in accordance with the requirements of the Federal Law of 21.11.2011 N 323-FZ "On the basics of protecting the health of citizens in the Russian Federation."

You may not qualify if:

  • Hemodynamically unstable patients
  • Severe renal impairment (GFR \<30 ml / min)
  • Moderate or severe liver failure (Child-Pugh Class B or C)
  • Oncological diseases (lasting more than 5 years)
  • Hypersensitivity to any component of the test food mixture
  • Uncertainty of the investigator about the willingness or ability of the subject to comply with the protocol requirements
  • Any other medical or non-medical reasons that, in the opinion of the physician, may prevent the patient from participating in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

GAUZ Bryansk city hospital №1

Bryansk, Russia

Location

GBUZ GKB named after VV Vinogradov DZM

Moscow, Russia

Location

Hospital named after V.D. Seredavin

Samara, Russia

Location

MeSH Terms

Conditions

Pressure UlcerStrokeBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain InjuriesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Mikhail Getman, Dr

    Enrollme.ru, LLC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 18, 2022

Study Start

June 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

July 18, 2022

Record last verified: 2022-07

Locations